SAB Biotherapeutics, Inc.
SABSAs of the close on Sep 25, 2026
Price
$3.29
Market cap
—
The cover-page share count does not match the latest report's share count
P/E (diluted TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
EPS (TTM)
—
A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How SAB Biotherapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: SAB Biotherapeutics, Inc. — 10-K filed Mar 9, 2026
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 26, 2026. The latest institutional report shown is dated Dec 31, 2023; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| MORGAN STANLEY | 2023-12-31 | 11,506 | $7.91K | SEC filing |
| JPMORGAN CHASE & CO | 2023-12-31 | 951 | $654 | SEC filing |
| BARCLAYS PLC | 2023-03-31 | 54 | Not shown | SEC filing |
- Each value is checked against SAB Biotherapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: no share price from within three months of its report date is on file, so it could not be checked.
3 filers have only one report here.
Independent insiders buying near the same time
- 2023-11-30–2023-12-07: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2023-11-29–2023-11-30: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2022-09-07–2022-09-13: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-10-13–2021-10-14: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-10-01–2021-10-01: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-01-14–2021-01-14: 3 event(s) across 3 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2023-12-07 | Sullivan Eddie Joe · Chief Executive Officer | Common Stock | P — Open market or private purchase | +1,740 | 0.88 | SEC filing |
| 2023-11-30 | King Michael · CHIEF FINANCIAL OFFICER | Common Stock | P — Open market or private purchase | +5,000 | 0.90 | SEC filing |
| 2023-11-29 | Reich Samuel J · Executive Chairman | Common Stock | P — Open market or private purchase | +11,000 | 0.89 | SEC filing |
| 2022-09-13 | HAMILTON CHRISTINE E · Director, 10% owner | Common Stock | P — Open market or private purchase | +10,000 | 0.73 | SEC filing |
| 2022-09-07 | Sullivan Eddie Joe · CHIEF EXECUTIVE OFFICER | Common Stock | P — Open market or private purchase | +14,000 | 0.74 | SEC filing |
| 2021-10-26 | Beyer Russell P · Chief Financial Officer | Common Stock | S — Open market or private sale | −278 | 7.90 | SEC filing |
| 2021-10-14 | Reich Samuel J · CEO and CFO | Common Stock | P — Open market or private purchase | +1,000 | 10.11 | SEC filing |
| 2021-10-13 | Katz Ilan · Director, 10% owner | Common Stock | P — Open market or private purchase | +500 | 10.11 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Kropotova Alexandra · CHIEF MEDICAL OFFICER | Common Stock | F — Payment of exercise price or tax by delivering securities | −988 | SEC filing |
| 2026-03-24 | Kropotova Alexandra · CHIEF MEDICAL OFFICER | Common Stock | F — Payment of exercise price or tax by delivering securities | −988 | SEC filing |
| 2026-02-03 | To Lucy · See Remarks | Stock option (right to buy) | A — Grant, award, or other acquisition | +2,400,000 | SEC filing |
| 2026-02-03 | Reich Samuel J · CEO | Stock option (right to buy) | A — Grant, award, or other acquisition | +4,800,000 | SEC filing |
| 2026-02-03 | Sullivan Eddie Joe · PRESIDENT | Stock option (right to buy) | A — Grant, award, or other acquisition | +3,000,000 | SEC filing |
| 2026-02-03 | Bausch Christoph Lawrence · CHIEF OPERATING OFFICER | Stock option (right to buy) | A — Grant, award, or other acquisition | +1,800,000 | SEC filing |
| 2026-02-03 | Kropotova Alexandra · CHIEF MEDICAL OFFICER | Stock option (right to buy) | A — Grant, award, or other acquisition | +2,400,000 | SEC filing |
| 2026-01-05 | ZACCARDELLI DAVID · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +240,000 | SEC filing |
Showing 8 of 27 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-02-28 | Spragens Jeffrey G · Director | Warrants | J — Other acquisition or disposition | +19,936 | SEC filing |
| 2023-02-28 | Reich Samuel J · Executive Chairman | Warrants | J — Other acquisition or disposition | +9,968 | SEC filing |
| 2023-02-28 | Reich Samuel J · Executive Chairman | Warrants | J — Other acquisition or disposition | −208,600 | SEC filing |
| 2022-05-20 | Reich Samuel J · Executive Chairman | Common Stock | J — Other acquisition or disposition | −2,500,127 | SEC filing |
| 2022-05-20 | Reich Samuel J · Executive Chairman | Common Stock | J — Other acquisition or disposition | +207,001 | SEC filing |
| 2022-05-20 | Spragens Jeffrey G · Director | Common Stock | J — Other acquisition or disposition | +299,002 | SEC filing |
Showing 6 of 6 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.